Hikal completes ANVISA GMP audit of Jigani unit

Hikal Ltd has successfully passed the Brazilian Health Regulatory Agency's (ANVISA) GMP audit for its manufacturing unit located at Jigani in Bengaluru, Karnataka. The inspection, carried out by ANVISA, Brazil GMP (Good Manufacturing Practices), was for multiple API's which occurred from April 14th to April 18th, 2025.

Sun Pharma gets 8 observations from USFDA for Halol facility

The US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited's Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations.